Overview
Massimo Cristofanilli is an Oncologist in New York, New York. Dr. Cristofanilli is highly rated in 6 conditions, according to our data. His top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, Paget Disease of the Breast, and Tissue Biopsy. Dr. Cristofanilli is currently accepting new patients.
His clinical research consists of co-authoring 312 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- POS
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1283 York Ave Fl 4, New York, NY 10065
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Steven Horwitz is a Hematologist and an Oncologist in New York, New York. Dr. Horwitz is highly rated in 26 conditions, according to our data. His top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration. Dr. Horwitz is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Alison Moskowitz is a Hematologist and an Oncologist in New York, New York. Dr. Moskowitz is highly rated in 32 conditions, according to our data. Her top areas of expertise are T-Cell Lymphoma, Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Moskowitz is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Gilles Salles is a Hematologist and an Oncologist in New York, New York. Dr. Salles is highly rated in 27 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Bone Marrow Transplant, and Splenectomy. Dr. Salles is currently accepting new patients.
Frequently Asked Questions about Dr. Massimo Cristofanilli
How do I make an appointment with Dr. Massimo Cristofanilli?
You can book an appointment with Dr. Massimo Cristofanilli by calling their office at 844-558-6066. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Massimo Cristofanilli a top-rated expert for Inflammatory Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Massimo Cristofanilli is classified as an Elite expert for Inflammatory Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Massimo Cristofanilli specialize in?
While Dr. Massimo Cristofanilli is a Oncology, they have specific expertise in Inflammatory Breast Cancer, Breast Cancer, and Triple-Negative Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Massimo Cristofanilli participate in research or clinical trials?
Yes. Dr. Massimo Cristofanilli has published 312 articles and abstracts on conditions like Inflammatory Breast Cancer. You can view a list of Dr. Massimo Cristofanilli's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Massimo Cristofanilli accept my insurance?
Dr. Massimo Cristofanilli accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 844-558-6066 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Cristofanilli isElite. Learn about Breast Cancer.
- Inflammatory Breast CancerDr. Cristofanilli isElite. Learn about Inflammatory Breast Cancer.
- Distinguished
- Paget Disease of the BreastDr. Cristofanilli isDistinguished. Learn about Paget Disease of the Breast.
- Triple-Negative Breast CancerDr. Cristofanilli isDistinguished. Learn about Triple-Negative Breast Cancer.
- Advanced
- AngiosarcomaDr. Cristofanilli isAdvanced. Learn about Angiosarcoma.
- Tissue BiopsyDr. Cristofanilli isAdvanced. Learn about Tissue Biopsy.
- Experienced
- AgranulocytosisDr. Cristofanilli isExperienced. Learn about Agranulocytosis.
- Bone TumorDr. Cristofanilli isExperienced. Learn about Bone Tumor.
- Brain TumorDr. Cristofanilli isExperienced. Learn about Brain Tumor.
- Colorectal CancerDr. Cristofanilli isExperienced. Learn about Colorectal Cancer.
- Gastrointestinal Stromal TumorDr. Cristofanilli isExperienced. Learn about Gastrointestinal Stromal Tumor.
- HER-2 Positive Breast CancerDr. Cristofanilli isExperienced. Learn about HER-2 Positive Breast Cancer.